Massachusetts General Cancer Center, Boston, Massachusetts
Massachusetts General Cancer Center offers the latest treatments and technologies for cancers of all types, including malignant pleural mesothelioma, malignant peritoneal mesothelioma, and lung cancer. Its experts specialize in the cancers that they treat, providing deep expertise and experience to meet the challenges of some of the most difficult malignancies.[1]
Massachusetts General Cancer Center specializes in compassionate, team-based, personalized care highlighted by innovations including targeted therapies, immunotherapies, and the only proton therapy site in New England. Its top-rated surgeons are trained in traditional, minimally invasive, robotic, and video-assisted surgeries. The center is also a National Comprehensive Cancer Center and a member of the National Comprehensive Cancer Network and is recognized as one of the top research hospitals in the country.[1]
Pleural Mesothelioma, Peritoneal Mesothelioma, and Lung Cancer Care at Massachusetts General Hospital
Massachusetts General Hospital’s Center for Thoracic Cancers is one of New England’s most experienced programs for the care of lung and other thoracic cancers, including pleural mesothelioma. Consistently ranked as one of the best in the country by U.S. News & World Report, the center provides individualized, compassionate care combined with the most advanced treatments and promising therapies.[2]
The professional medical team at Massachusetts General follows a multidisciplinary approach that leads to a personalized, coordinated, compassionate treatment plan that considers each patient’s condition and prognosis as well as their personal goals. Treatment options include surgery, chemotherapy, radiation, or whatever combination of those protocols is best suited to their condition, and the department works hand-in-hand with the Division of Thoracic Surgery for patients requiring surgical intervention using complex, minimally invasive, or robotic techniques. Patients may also benefit from the use of immunotherapy and targeted treatments.[2]
Patients diagnosed with malignant peritoneal mesothelioma will receive care from the Peritoneal Surface Malignancy program, where medical oncologists work hand-in-hand with oncologic surgeons in the delivery of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, a complex procedure that combines traditional open surgery to remove all visible tumor material and administration of a heated solution of concentrated chemotherapy that kills any microscopic cancer cells left behind.
Notable Staff and Mesothelioma Specialists
Patients seeking care at Massachusetts General Hospital for lung cancer or either pleural or peritoneal mesothelioma will find themselves in experienced hands. The Center for Thoracic Cancers has assembled a dedicated team of physicians from across the oncology spectrum led by thoracic surgeons Dr. Yolonda Colson, Dr. Michael Lanuti, medical oncologists Dr. Justin Gainor and Dr. Jennifer Temel, and radiation oncologist Dr. Henning Willers.[2]
Patients diagnosed with malignant peritoneal mesothelioma will benefit from the care of Dr. James Cusack, a gastrointestinal surgeon who is the director of the Peritoneal Surface Malignancy Program at Massachusetts General Hospital.[3]
